How do companies in the mental health market make money?
In our mental health market deck, you will find everything you need to understand the market
SUMMARY
Companies in the mental health market make money mainly by connecting patients to healthcare budgets that already exist: insurer reimbursement, employer benefits, out-of-pocket subscriptions, provider-infrastructure economics, intensive treatment programs and, increasingly, reimbursed software.
The biggest shift is away from pure consumer payment. In Talkspace's latest reported mix, more than 94% of revenue came from health-plan payors and enterprise customers rather than consumer subscriptions.
Direct-to-consumer therapy can still become very large, but BetterHelp shows how fragile the economics can be when paid acquisition does the heavy lifting. Advertising and marketing consumed about 53% of quarterly revenue while adjusted EBITDA margin was roughly 0.2%.
The strongest structure today sits one layer above the clinician. Headway and Grow Therapy can participate in insured care across large independent-provider networks without putting every therapist on payroll.
Psychiatry and virtual intensive outpatient care can produce more revenue per patient because reimbursement is attached to scarcer specialists or much denser treatment episodes. The trade-off is straightforward: both remain labor-heavy healthcare businesses.
Employer mental health benefits are becoming harder to sell on engagement alone. The better vendors increasingly need to show lower total healthcare spending, faster access to care or measurable clinical improvement.
Meditation apps and modern EAPs are turning into front doors for a broader care system. Low-cost content and coaching can engage a large population, while the more expensive cases are routed into therapy, psychiatry or specialty care.
Reimbursed digital therapeutics may eventually have the best marginal economics in the market because software can generate treatment revenue without adding a clinician hour every time usage rises. The reimbursement path is real now, but commercial scale is still being proven.
AI is not yet a major standalone mental health revenue model. Its clearest economic value today is in documentation, routing, engagement and back-office automation that let human-care businesses deliver more reimbursed work with less administrative time.
The broader pattern explains the current consolidation wave: controlling navigation between levels of care creates more ways to capture spending from the same patient population. Today, the most convincing models are the ones tied closely to insurance, employers and healthcare infrastructure rather than those relying on repeated consumer acquisition.
What do mental health companies actually sell?
In the U.S. mental health market, companies mainly make money from subscriptions, insured clinical visits, employer benefits, provider infrastructure and intensive treatment programs.
That sounds obvious until we put companies next to each other. BetterHelp sells access to therapists. Talkspace bills insurers for therapy and psychiatry sessions. Headway sits between insurers and independent clinicians and keeps part of certain session payments. Spring Health sells employers and health plans access to a broader care system. Talkiatry runs a national psychiatry practice. Charlie Health sells multi-week intensive outpatient treatment. Big Health is trying to get therapeutic software reimbursed through medical billing codes.
The differences are huge economically. A meditation app can add another user for almost no delivery cost. A therapy company needs another clinician hour. A provider platform can earn from thousands of therapists it does not employ. An intensive outpatient program can generate many reimbursed clinical hours from one patient over several weeks.
Because reimbursement varies sharply by country, most of the hard financial evidence we can actually compare comes from the U.S. market. The basic models, however, are useful well beyond the U.S.
| Model | What gets paid for | Main payer | Examples |
|---|---|---|---|
| Consumer subscription | App or therapy access | Patient | BetterHelp, Calm |
| Insured outpatient care | Therapy or psychiatry visits | Insurer + patient | Talkspace, Talkiatry |
| Provider infrastructure | Insurance-enabled sessions and practice support | Insurer economics and/or clinician | Headway, Alma |
| Employer mental health benefit | Access, navigation and care | Employer or health plan | Spring Health, Headspace |
| Intensive treatment | Multi-week care program | Insurer | Charlie Health |
| Digital therapeutic | Prescribed software treatment | Medicare, insurer or health system | Big Health |
Who pays for online mental health care now: patients, employers or insurers?
Insurers and employers now sit at the center of the strongest online mental health businesses, while direct consumer payment is becoming less important for several of the companies we can actually measure.
Talkspace gives us the cleanest public example. In its latest reported quarter before being acquired, Talkspace generated $61.7 million of revenue. Health-plan payors contributed $51.5 million, direct-to-enterprise customers another $6.9 million and consumer subscriptions only $3.3 million. More than 94% of revenue therefore came from somewhere other than a consumer subscription.
The direction is even clearer than the mix. Payor revenue grew 27.1% from the previous year while consumer subscription revenue fell 25.4%. Completed insured sessions rose 23%, and Talkspace had 39 health-plan customers compared with 31 a year earlier.
Grow Therapy has built the business around the same payer shift without going through Talkspace's earlier consumer phase. Its latest company disclosures put the network at roughly 27,000 mental health professionals, with about 230 million Americans able to access Grow through their health plan. Earlier this year, Grow raised $150 million at a $3 billion valuation while describing insurers, employers and health systems as its core commercial partners.
The pattern is hard to miss. Consumers still choose the therapist and still pay deductibles or copays, but increasingly they are using insurance money that already exists rather than funding the whole treatment themselves.
This market map, featured in our mental health market deck, highlights top companies and startups in the mental health market
Why does direct-to-consumer online therapy struggle to make money?
Direct-to-consumer online therapy can produce huge revenue, but the latest BetterHelp numbers show that acquiring enough paying users can consume almost the entire economic advantage.
BetterHelp remains massive. It produced $212.6 million of revenue in its latest quarter, which still implies a business operating at close to a billion-dollar annual revenue pace.
The problem appears lower down the income statement. BetterHelp spent $111.7 million on advertising and marketing during that quarter, equivalent to about 53% of revenue. The direct cost of providing the service was another $60.8 million. Adjusted EBITDA came to only $0.5 million, a margin of roughly 0.2%.
The deterioration is also continuing. Revenue fell 12% year over year and average monthly paying users fell 11% to 346,000. Across the first half of the year, BetterHelp spent $228.5 million on advertising and marketing against $431 million of revenue.
Teladoc's Integrated Care segment provides a useful contrast. Its latest quarterly adjusted EBITDA margin was 16.5%, against 0.2% for BetterHelp. The businesses are not perfectly comparable, but the gap says plenty about distribution. Winning one institutional contract that gives access to a large population can be far cheaper than repeatedly finding individuals at the exact moment they decide they want therapy.
BetterHelp itself is now pushing further into insurance-covered services. Teladoc said the shift in demand toward insurance has happened faster than BetterHelp has been able to build enough provider capacity. Even the industry's most famous consumer therapy brand is moving in the same direction.
| Latest reported quarter | BetterHelp |
|---|---|
| Revenue | $212.6M |
| Revenue growth | -12% |
| Average monthly paying users | 346,000 |
| Paying-user growth | -11% |
| Advertising and marketing | $111.7M |
| Marketing as % of revenue | ~53% |
| Adjusted EBITDA margin | ~0.2% |
If you want more recent data on this point, please see our latest mental health market report.
How do Headway and Grow Therapy make money if therapists aren't employees?
Headway and Grow Therapy make money by organizing insured mental healthcare around independent clinicians, which lets them participate in care revenue without putting every therapist on payroll.
Headway explains its model unusually clearly. It negotiates reimbursement rates with insurers, offers clinicians a set payout for each covered session and keeps a small portion of the session payment when the negotiated rate leaves enough room. Some lower-paying contracts generate little or nothing for Headway.
The scale has become substantial. Headway currently advertises more than 80,000 therapists and psychiatrists, more than 40 million completed sessions and relationships covering more than 100 insurance plans.
What clinicians get in return explains why the model works. Headway handles credentialing, eligibility checks, billing and claims. It also pays providers twice a month regardless of when the insurer pays Headway, and says it absorbs the loss when certain claims are denied. The therapist gives up part of the economics but gets rid of work, collection delays and some payment risk.
Grow Therapy has arrived at a similar destination with roughly 27,000 providers. Its platform combines patient acquisition, insurance administration, billing, scheduling and clinical software. Grow has also started selling directly to employers, but with an interesting pricing choice: the company says employers pay for care that employees actually use rather than a flat fee for every eligible employee.
This model has a powerful feature. A traditional therapy practice grows by hiring more therapists. Headway and Grow can grow by adding independent practices that bring their own clinical labor. The expensive part of care remains human, while much of the administrative layer can be spread over millions of sessions.
As this chart shows, and as featured in our mental health market deck, search interest in men’s mental health has been rising steadily
Why do employers still pay for mental health benefits?
Employers still have a strong reason to pay for mental healthcare, but these days vendors have to show that the benefit can reduce larger healthcare costs instead of simply reporting that employees like it.
A peer-reviewed JAMA Network Open study gives us one of the better pieces of evidence. Researchers studied 13,990 employees and dependents eligible for Spring Health across seven employers. Compared with matched patients receiving care through the normal health-plan pathway, program participants had medical spending increases that were $164 lower per member per month.
After including the cost of the mental health program, the researchers estimated $1,070 of savings per participant during the first program year. Every $100 spent on the program was associated with $190 less in medical claims. Behavioral healthcare use actually increased 47%; the savings came because higher mental health spending was more than offset by lower physical-health spending.
We should keep the confidence level appropriate here. This was a retrospective cohort study, rather than a randomized experiment, and it evaluated one specific program. It gives employers credible evidence that an integrated mental health benefit can save money, not proof that every workplace wellness product does.
That distinction is especially relevant now. Spring Health's latest workplace survey found that 95% of HR professionals consider mental health at least somewhat important to business strategy, yet only 9% said their current mental or behavioral health solution was reducing health-plan spending.
So employers have not stopped caring about mental health benefits. They have become much harder customers. The vendor increasingly has to answer a financial question: what expensive care, absence or deterioration did this program prevent?
Are traditional EAPs still worth paying for?
Traditional employee assistance programs still have a business, but employers are pushing them toward a broader model that can handle everyday stress, therapy and serious clinical needs without sending everyone into the same type of care.
Headspace shows where the EAP is going. It now works with more than 4,000 employers and health plans and combines meditation, coaching, therapy, psychiatry, crisis support and work-life services in the same employer product.
Its own framing is revealing. Headspace estimates that around 30% of a workforce may need therapy or crisis-oriented support while the other 70% can often start with lower-intensity help. The idea is to avoid paying therapist-level costs for every person who is stressed, while still giving the more serious cases a quick route into clinical care.
Calm is moving in a similar direction. Calm Health is sold to employers and health plans as a front door that screens members, provides clinical programs and directs them toward existing therapy, EAP or health-plan benefits when needed. In data from one national payer, Calm says 37% of users who screened with moderate-to-severe anxiety or depression went on to engage in therapy.
The business problem with the old EAP was often low usage. The problem with an unlimited therapy benefit can be the opposite: usage becomes expensive. Today's products are trying to manage that middle ground by deciding who needs content, coaching, therapy, psychiatry or specialty care.
This chart, featured in our mental health market deck, illustrates yearly VC investment in mental health startups
Is online psychiatry a better business than online therapy?
Online psychiatry currently looks like a stronger revenue model than generic online therapy, although we still do not have enough public margin data to say that it is a more profitable business.
Talkiatry shows why investors like the category. The company now employs more than 800 full-time psychiatrists, has completed more than three million patient visits and works with more than 100 insurers covering over 170 million people. It raised another $210 million this year, taking its total funding above $400 million.
Psychiatry has a few economic advantages. Reimbursement can be attractive, psychiatrists remain difficult to find in many markets, and medication management creates recurring follow-up visits. Talkiatry has also built referral relationships with more than 50 health systems rather than relying entirely on paid consumer acquisition.
Those health-system relationships are getting deeper. Talkiatry launched software that sits inside more than 30 cloud-based medical-record systems and lets physicians refer patients into psychiatry without leaving their usual workflow. The software is free to partners because the real monetization happens when referred patients become insured psychiatric visits.
There is still a clear limit. More psychiatric demand means more psychiatrists, and Talkiatry directly employs them. This remains a healthcare service company with software wrapped around it. Talkiatry has not disclosed profitability, so claims that psychiatry automatically produces great margins would go beyond the evidence.
What we can say with more confidence is that psychiatry gives a platform something generic therapy often lacks: scarce clinical supply, strong payer demand and a recurring medical relationship.
If you want more recent data on this point, please see our latest mental health market report.
Why can virtual intensive outpatient care make more money per patient?
Virtual intensive outpatient care can generate much more revenue from one mental health patient than weekly therapy because the insurer is paying for a whole treatment episode with several clinical sessions each week.
Charlie Health is a good example. Its virtual intensive outpatient programs generally combine group therapy, individual therapy and family therapy over roughly six to twelve weeks. The company currently works with more than 600 insurance plans, and says 99% of its clients use insurance.
One ordinary outpatient therapy patient might generate one reimbursed visit in a week. An intensive outpatient patient can generate several hours of reimbursed treatment during that same period. We do not have Charlie Health's private reimbursement rates, so putting a dollar figure on the difference would be guesswork. The difference in treatment volume is already enough to explain the revenue logic.
The payer also compares the program with more expensive alternatives. IOP care is aimed at patients who need more support than weekly therapy but do not necessarily need residential or inpatient treatment. Avoiding even a fraction of emergency visits, hospitalizations or residential stays can make a relatively intensive virtual program financially reasonable for an insurer.
Margins are a separate question. Charlie Health still needs clinicians, care coordinators, intake staff and utilization-management teams. The attraction comes from higher revenue per patient and a valuable position in the care ladder, rather than unusually cheap treatment delivery.
This chart, featured in our mental health market deck, shows why Talkspace is winning in mental health
Can mental health software finally get paid like a medical treatment?
Mental health software finally has a real reimbursement path, but the business model is still early enough that we would not call digital therapeutics a proven winner yet.
For years, the category had an ugly mismatch: software could scale beautifully, but nobody knew who was supposed to pay for it. Pear Therapeutics became the best-known warning. The company won FDA clearances for prescription digital treatments but struggled to build widespread reimbursement and filed for bankruptcy in 2023.
Medicare has since created specific billing codes for eligible Digital Mental Health Treatment devices used as part of behavioral healthcare. That gives clinicians a defined way to bill for supplying and managing certain FDA-cleared software treatments.
Big Health is now testing whether that changes the commercial outcome. Its SleepioRx product treats insomnia and DaylightRx treats generalized anxiety disorder. Both are FDA-cleared, and Big Health says they are among only nine treatments currently in Medicare's Digital Mental Health Treatment category. The company raised $23.7 million this year to expand adoption through providers and health systems.
The attraction is obvious once reimbursement works. Big Health sells a 90-day software treatment without needing to schedule a therapist for every hour the patient uses it. That is one of the few mental health models where revenue can potentially grow much faster than clinical labor.
We are still waiting for proof at commercial scale. New billing codes remove one major obstacle, but clinicians still have to prescribe the products, patients have to use them and insurers beyond Medicare have to decide how broadly they will pay.
If you want more recent data on this point, please see our latest mental health market report.
Can meditation apps like Headspace and Calm still make money?
Meditation apps can still make money, but Headspace and Calm are increasingly using their consumer products as an entry point into employer and health-plan mental health spending.
Headspace today looks very different from the meditation subscription people first knew. Its organizational product includes coaching, therapy, psychiatry, EAP services, care navigation and specialty referrals. The company says it has delivered more than three million care sessions through employers and health plans.
Headspace has also recently expanded referral partnerships for conditions such as eating disorders, neurodiversity and higher-acuity mental health needs. A member can start inside Headspace and be moved into more specialized care without Headspace having to build every specialty service itself.
Calm is making a comparable move through Calm Health. It still benefits from a very recognizable wellness brand, but Calm Health is designed for employers and insurers and can direct users into other covered benefits. A recent Solera Health partnership alone opened Calm Health to more than 16 million additional eligible people.
This gives the old meditation model a more useful role. Low-cost digital content can engage a very large population. The company then becomes the front door through which some users move toward benefits and treatments carrying much larger healthcare budgets.
Consumer subscriptions have not disappeared. They simply no longer explain the most interesting part of where these companies are going.
This chart, featured in our mental health market deck, illustrates yearly funding for mental health startups
Is AI actually becoming a mental health business model?
AI is making mental health companies more efficient right now, but most of the money still comes from human care and insurance reimbursement rather than from charging patients to talk to an AI therapist.
Grow Therapy shows the more realistic model. The company gives clinicians AI-assisted documentation tools and says provider documentation time has fallen by nearly 70% since their introduction. Grow has also launched an AI coach for patients between sessions with clinician oversight.
At millions of patient hours, cutting documentation time can create real economic value. A therapist who spends less time writing notes has more capacity for paid clinical work. The same software can also lower administrative cost per visit as the platform gets larger.
Talkiatry is using AI in a similar way: automating back-office work, supporting patient engagement and helping run a national psychiatric practice. Spring Health has gone further with its Guide product, which interacts directly with members while remaining connected to the company's clinical system.
For now, the business model is indirect. AI helps a company deliver reimbursed care with fewer administrative minutes, route patients more accurately and keep people engaged between appointments.
Standalone AI therapy may eventually become its own major revenue category. We do not yet have evidence that it has.
Are mental health companies really getting paid for outcomes yet?
Most mental health companies are still paid for access, sessions or treatment programs, while outcomes increasingly decide who wins the contract and how good the reimbursement can become.
Headway is a useful example. The company still earns around individual insured sessions. Yet Headway says some of its relationships with health plans, particularly contracts with better reimbursement rates, depend on measures such as speed to care and clinical outcomes.
Spring Health reaches the same destination from the employer side. Its contracts are not simply a pure payment-for-remission model, but the company has built its sales pitch around measured clinical improvement and healthcare savings. The JAMA study showing a 1.9x return on program cost gives benefits teams something more concrete than engagement statistics.
Grow Therapy is moving the same way. It has built systematic outcomes measurement into the platform and is increasingly talking to insurers about symptom improvement and total cost rather than only network size.
So value-based care is already changing the economics, just not in the simplistic form people sometimes imagine. The therapist is still often paid for the visit. The platform increasingly gets the next contract, the better rate or the larger population because it can show what happened after those visits.
This chart, featured in our mental health market deck, compares the main business model options for tele-mental health platforms
Which mental health business model has the best economics today?
The best mental health business model today appears to be insurance-connected infrastructure that can grow care volume without employing every clinician, although private-company reporting means we can rank the structures more confidently than the actual margins.
Headway is the clearest version. More than 80,000 independent clinicians sit on infrastructure that handles insurance contracts, claims, payments and patient matching. Revenue can grow with session volume without Headway carrying the salary of every therapist on the network.
Grow Therapy has many of the same advantages while adding employer and health-system distribution. Spring Health and Headspace are attractive for a different reason: one institutional sale can unlock thousands or millions of eligible members, which avoids the advertising burden visible at BetterHelp.
Psychiatry and intensive outpatient care can generate more revenue per patient and solve problems insurers genuinely need solved, but they remain labor-heavy healthcare businesses. Digital therapeutics could eventually have the best marginal economics of all, although Big Health is still proving that the new reimbursement pathway can produce a large commercial market.
Direct-to-consumer therapy now looks weakest structurally. BetterHelp's latest 0.2% quarterly adjusted EBITDA margin is difficult to ignore when evaluating a model that spends more than half of revenue on advertising.
| Model | How good the economics look today | Main problem |
|---|---|---|
| Provider network + insurance infrastructure | Strongest structure | Needs good insurer rates and enough session volume |
| Employer / health-plan platform | Strong | Long sales cycles and growing ROI scrutiny |
| Psychiatry | Attractive revenue model | Expensive clinical workforce |
| Virtual intensive care | High revenue per patient | Labor-intensive and dependent on authorization |
| Reimbursed digital therapeutics | Highest theoretical scalability | Commercial reimbursement still early |
| Direct-to-consumer therapy | Weakest of the scaled models we can observe | Customer acquisition cost |
If you want more recent data on this point, please see our latest mental health market report.
Why are mental health companies merging into bigger care platforms?
Mental health companies are combining because owning the route from first contact to higher-acuity treatment is becoming more valuable than owning one isolated mental health product.
The scale of consolidation is broader than a couple of headline deals. Trilliant Health's 2026 behavioral health report counted 167 sector transactions during 2025, with mental health responsible for 111 of them. That is roughly two thirds of all behavioral health deals.
Spring Health's acquisition of Alma shows what buyers want. Spring brought employer and health-plan distribution. Alma brought independent clinicians, payer contracts and insurance infrastructure. The completed combination says it now reaches more than 170 million lives globally.
Universal Health Services has gone even further. Talkspace had already become overwhelmingly dependent on insured and enterprise revenue. UHS has now completed its roughly $835 million acquisition of the company and connected its virtual platform with a physical network that includes more than 380 inpatient behavioral health facilities and 120 outpatient behavioral health locations.
That combination can capture much more of one patient's spending. Someone may enter through virtual therapy, move into psychiatry, require an outpatient program and eventually need inpatient care. UHS can now participate across far more of that journey.
Headspace is pursuing the same logic without buying every provider. Its expanding specialty referral network lets it connect members to companies such as Charlie Health when they need care beyond Headspace's own offering.
The direction is becoming clear. Mental healthcare is fragmented, and companies that control navigation between levels of care gain more ways to make money from the same patient population.
This chart, featured in our mental health market deck, shows how market revenue is split across customer segments in the mental health market
So how do mental health companies actually make money today?
Mental health companies make the strongest money today by connecting patients to healthcare budgets that already exist: insurer reimbursement, employer benefits and health-system spending.
The old picture of the market as a collection of therapy and meditation apps is increasingly outdated. Direct consumer subscriptions can still create large businesses, but BetterHelp's latest results show how punishing consumer acquisition can become. Meanwhile, insurer-funded therapy networks are growing, employer platforms are being judged on healthcare savings, psychiatry companies are building national medical groups and intensive-care providers are monetizing much larger treatment episodes.
The most interesting economics sit one layer above the therapist. Headway, Grow Therapy, Alma and similar platforms organize credentialing, reimbursement, claims, payments and patient flow across huge clinician networks. They can take part in more care without hiring one employee for every new patient.
Higher up the care ladder, Talkiatry and Charlie Health earn more from each patient by delivering more specialized treatment. At the other extreme, companies such as Big Health are trying to make software itself reimbursable, which could eventually remove much of the labor constraint.
So the mental health market is increasingly behaving like healthcare infrastructure. Technology still matters enormously, but the companies building the strongest businesses are using it to control access to clinicians, insurers, employers, referrals and reimbursement. Whoever makes those flows easier can take a piece of an enormous pool of existing healthcare spending.
If you want more recent data on this point, please see our latest mental health market report.
OUR METHODOLOGY
This analysis compares how mental health companies make money and which business models have the strongest economics today. Because reimbursement varies sharply by country and the most comparable financial evidence is concentrated in the United States, the hard numbers are mainly U.S.-based even though the underlying business models are relevant more broadly.
We compared the economic variables that actually change the model: revenue and margins, payer mix, customer-acquisition spending, provider scale, insurance coverage, treatment intensity, reimbursement pathways, clinical outcomes, healthcare-cost impact and distribution relationships. We looked at those factors together rather than treating growth, funding, valuation or network size as proof that a model works.
Public companies provide the cleanest financial evidence, so Talkspace and Teladoc's BetterHelp segment carry more weight when we discuss observed revenue mix, marketing intensity and margins. For private companies such as Headway, Grow Therapy, Spring Health, Talkiatry and Charlie Health, we rely more on operating scale, payer relationships, treatment structure, provider networks, utilization and disclosed outcomes.
We also separate demonstrated economics from theoretical scalability. Insurance-connected provider infrastructure, psychiatry and intensive outpatient care already have visible payer demand, while digital therapeutics may ultimately scale with much less clinical labor but are still proving whether the new reimbursement pathway can support a large commercial market.
Clinical and cost-savings claims are treated more cautiously than operating metrics. The Spring Health evidence cited above comes from a peer-reviewed retrospective cohort study, so we use it as evidence that an integrated employer benefit can reduce healthcare spending in that setting, not as proof that every mental health benefit produces the same return.
Key sources include Talkspace's Q1 2026 Form 10-Q for payer mix and insured-session data, Teladoc Health's Q2 2026 results for BetterHelp revenue, marketing and adjusted EBITDA, and the JAMA Network Open study of Spring Health for healthcare-cost and ROI evidence.
We also use company operating disclosures from Headway, Grow Therapy, Talkiatry and Charlie Health, alongside CMS guidance on Digital Mental Health Treatment billing and Big Health's Medicare reimbursement material for the digital-therapeutics section.
For consolidation, the analysis draws on Trilliant Health's 2026 Behavioral Health Report, Spring Health's disclosure on the Alma combination and Universal Health Services' investor relations material on the completed Talkspace acquisition.
This chart, featured in our mental health market deck, shows how therapy matchmaking platform technology has evolved over time
Related blog posts
